Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10671228rdf:typepubmed:Citationlld:pubmed
pubmed-article:10671228lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:10671228lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:10671228lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:10671228lifeskim:mentionsumls-concept:C1704387lld:lifeskim
pubmed-article:10671228lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:10671228lifeskim:mentionsumls-concept:C1522642lld:lifeskim
pubmed-article:10671228lifeskim:mentionsumls-concept:C0205341lld:lifeskim
pubmed-article:10671228lifeskim:mentionsumls-concept:C0679932lld:lifeskim
pubmed-article:10671228lifeskim:mentionsumls-concept:C1947978lld:lifeskim
pubmed-article:10671228lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:10671228lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:10671228pubmed:issue2lld:pubmed
pubmed-article:10671228pubmed:dateCreated2000-3-14lld:pubmed
pubmed-article:10671228pubmed:abstractTextTransgenic mouse experiments indicate that autoreactive B cells are eliminated upon encounter with membrane self-antigen. In this study we tested how B cell tolerance to MHC class I antigens is affected by altering the frequency of antigen-carrying cells in mixed bone marrow (BM) chimeras. When antigen-bearing cells are present at low frequency, the reactive B cells and their antigens may coexist in the peripheral lymphoid organs, but under these conditions the B cells are functionally anergic and have a shortened lifespan. Such putative anergic cells are strongly deleted in the presence of additional, non-antigen-bearing, non-transgenic B cells. Since the antigen concentration on the surface of each antigen-bearing cell should be high, these results suggest that for efficient deletion of autoreactive B cells multiple antigen encounters may be required, particularly when cellular competition is weak. These results have implications for the therapeutic use of BM chimerism to induce B cell tolerance to grafts.lld:pubmed
pubmed-article:10671228pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10671228pubmed:languageenglld:pubmed
pubmed-article:10671228pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10671228pubmed:citationSubsetIMlld:pubmed
pubmed-article:10671228pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10671228pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10671228pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10671228pubmed:statusMEDLINElld:pubmed
pubmed-article:10671228pubmed:monthFeblld:pubmed
pubmed-article:10671228pubmed:issn0014-2980lld:pubmed
pubmed-article:10671228pubmed:authorpubmed-author:LangJJlld:pubmed
pubmed-article:10671228pubmed:authorpubmed-author:NemazeeDDlld:pubmed
pubmed-article:10671228pubmed:issnTypePrintlld:pubmed
pubmed-article:10671228pubmed:volume30lld:pubmed
pubmed-article:10671228pubmed:ownerNLMlld:pubmed
pubmed-article:10671228pubmed:authorsCompleteYlld:pubmed
pubmed-article:10671228pubmed:pagination689-96lld:pubmed
pubmed-article:10671228pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:10671228pubmed:meshHeadingpubmed-meshheading:10671228...lld:pubmed
pubmed-article:10671228pubmed:meshHeadingpubmed-meshheading:10671228...lld:pubmed
pubmed-article:10671228pubmed:meshHeadingpubmed-meshheading:10671228...lld:pubmed
pubmed-article:10671228pubmed:meshHeadingpubmed-meshheading:10671228...lld:pubmed
pubmed-article:10671228pubmed:meshHeadingpubmed-meshheading:10671228...lld:pubmed
pubmed-article:10671228pubmed:meshHeadingpubmed-meshheading:10671228...lld:pubmed
pubmed-article:10671228pubmed:meshHeadingpubmed-meshheading:10671228...lld:pubmed
pubmed-article:10671228pubmed:meshHeadingpubmed-meshheading:10671228...lld:pubmed
pubmed-article:10671228pubmed:meshHeadingpubmed-meshheading:10671228...lld:pubmed
pubmed-article:10671228pubmed:meshHeadingpubmed-meshheading:10671228...lld:pubmed
pubmed-article:10671228pubmed:year2000lld:pubmed
pubmed-article:10671228pubmed:articleTitleB cell clonal elimination induced by membrane-bound self-antigen may require repeated antigen encounter or cell competition.lld:pubmed
pubmed-article:10671228pubmed:affiliationUniversity of Colorado Health Sciences Center, Barbara Davis Center for Juvenile Diabetes, Denver, USA.lld:pubmed
pubmed-article:10671228pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10671228pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10671228pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed